Patents Assigned to Aragon Pharmaceuticals, Inc.and Sloan -Kettering Institute for Cancer Research
  • CRYSTALLINE FORMS OF AN ANDROGEN RECEPTOR MODULATOR
    Publication number: 20150133481
    Abstract: Described herein are amorphous and crystalline forms of the androgen receptor modulator 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide. Also described are pharmaceutical compositions suitable for administration to a mammal that include the androgen receptor modulator, and methods of using the androgen receptor modulator, alone and in combination with other compounds, for treating diseases or conditions that are associated with androgen receptor activity.
    Type: Application
    Filed: June 4, 2013
    Publication date: May 14, 2015
    Applicant: Aragon Pharmaceuticals, Inc.and Sloan -Kettering Institute for Cancer Research
    Inventors: Anna Dilhas, Mark R. Herbert, Ouathek Ouerfelli, Nichola D. Smith